NDC25021-0806-01: HALOPERIDOL INJECTION.
The HALOPERIDOL INJECTION is a the manufacturer industrial component. Key specifications include secondary_container_type: VIAL, total_primary_container_quantity: 10, primary_container_content_quantity: 5.0 MILLIGRAMS OR 1.0 MILLILITERS, part_name_assigned_by_controlling_agency: HALOPERIDOL LACTATE 5 MG/ML VIAL, 10S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-683-6307, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| secondary_container_type | VIAL |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 5.0 MILLIGRAMS OR 1.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | HALOPERIDOL LACTATE 5 MG/ML VIAL, 10S |
| NSN | 6505-01-683-6307 |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.0 MILLIGRAMS OR 1.0 MILLILITERS |
| SECONDARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | HALOPERIDOL INJECTION, USP; 5 MG/ML VIAL, 10 VIALS PER PACKAGE. STERILE, NONPYROGENIC. THE CONTAINER CLOSURE IS NOT MADE WITH NATURAL RUBBER LATEX.S TORE AT 20 TO 25 C (68 TO 77 F). SEE USP CONTROLLED ROOM TEMPERATURE. DO NOT FREEZE. PROTECT FROM LIGHT. RETAIN IN CARTON UNTIL TIME OF USE. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | HALOPERIDOL LACTATE 5 MG/ML VIAL, 10S |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |